Having trouble accessing articles? Reset your cache.

Zanolimumab: Phase II data

The open-label Phase II Hx-CD4-109 trial in 21 patients showed that 12 weekly IV

Read the full 140 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE